Onconova Therapeutics Inc (OQ:ONTX)

Business Focus: Biopharmaceuticals

Competitors with Recent Insider Filings
Biogen (OQ:BIIB)
Allakos (OQ:ALLK)
BioMarin Pharmaceutical (OQ:BMRN)
Latest 10 SEC filings (by transaction date) for ONTX within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET July 21st, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Jul 11/19 Jul 10/19 Tyndall Capital Partners L P Indirect Ownership Common Stock S - Open market or private sale -2,742 $2.81
Jul 11/19 Jul 9/19 Tyndall Capital Partners L P Indirect Ownership Common Stock S - Open market or private sale -8,185 $2.84
Jul 1/19 Jun 27/19 Tyndall Capital Partners L P Indirect Ownership Common Stock S - Open market or private sale -1,458 $3.45
Jun 27/19 Jun 25/19 Tyndall Capital Partners L P Indirect Ownership Common Stock S - Open market or private sale -1,380 $3.40
Dec 14/18 Dec 14/18 Oler Abraham N. Direct Ownership Stock Option (right to purchase) Form 3 : Initial Statement of Beneficial Ownership of Securities    
Apr 8/19 Dec 12/18 Maniar Manoj Direct Ownership Stock Option (right to purchase) A - Grant, award or other under Rule 16b-3(d) 5,000  
Nov 7/18 Nov 5/18 Woodman Richard Charles Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 20,000  
Aug 29/18 Aug 29/18 Hoffman Michael B Indirect Ownership Common Stock S - Open market or private sale -29,999 $0.451
Aug 29/18 Aug 28/18 Hoffman Michael B Indirect Ownership Common Stock S - Open market or private sale -30,000 $0.457
Aug 29/18 Aug 28/18 Hoffman Michael B Indirect Ownership Common Stock S - Open market or private sale -20,000 $0.445
Sign up for a free account or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for ONTX within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET July 21st, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Jul 11/19 Jul 10/19 Tyndall Capital Partners L P Indirect Ownership Common Stock S - Open market or private sale -2,742 $2.81
Jul 11/19 Jul 9/19 Tyndall Capital Partners L P Indirect Ownership Common Stock S - Open market or private sale -8,185 $2.84
Jul 1/19 Jun 27/19 Tyndall Capital Partners L P Indirect Ownership Common Stock S - Open market or private sale -1,458 $3.45
Jun 27/19 Jun 25/19 Tyndall Capital Partners L P Indirect Ownership Common Stock S - Open market or private sale -1,380 $3.40
Apr 8/19 Dec 12/18 Maniar Manoj Direct Ownership Stock Option (right to purchase) A - Grant, award or other under Rule 16b-3(d) 5,000  
Dec 14/18 Dec 14/18 Oler Abraham N. Direct Ownership Stock Option (right to purchase) Form 3 : Initial Statement of Beneficial Ownership of Securities    
Nov 7/18 Nov 5/18 Woodman Richard Charles Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 20,000  
Aug 29/18 Aug 29/18 Hoffman Michael B Indirect Ownership Common Stock S - Open market or private sale -29,999 $0.451
Aug 29/18 Aug 28/18 Hoffman Michael B Indirect Ownership Common Stock S - Open market or private sale -30,000 $0.457
Aug 29/18 Aug 28/18 Hoffman Michael B Indirect Ownership Common Stock S - Open market or private sale -20,000 $0.445
Sign up for a free account or login above to see all SEC filings within the past 6 months.
Sign up for a free account or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now
Comment On!
140

Twitter

Search (past week) for $ONTX

StockTwits